Margoni, Monica http://orcid.org/0000-0002-9232-8964
Franciotta, Silvia
Poggiali, Davide
Riccardi, Alice
Rinaldi, Francesca
Nosadini, Margherita
Sartori, Stefano
Anglani, Maria Giulia
Causin, Francesco
Perini, Paola
Gallo, Paolo
Article History
Received: 20 January 2020
Revised: 20 February 2020
Accepted: 22 February 2020
First Online: 5 March 2020
Compliance with ethical standards
:
: Monica Margoni reports grants from Teva, grants from Genzyme Sanofi, grants from Merck Serono, grants from Biogen Idec, and grants and personal fees from Novartis, during the conduct of the study. Silvia Franciotta, Davide Poggiali, Alice Riccardi, Margherita Nosadini, Stefano Sartori, Maria Giulia Anglani, and Francesco Causin have nothing to disclose. Francesca Rinaldi reports grants and personal fees from Genzyme Sanofi, grants and personal fees from Merck Serono, grants and personal fees from Biogen Idec, and grants from Novartis, during the conduct of the study. Paola Perini reports grants and personal fees from Merck Serono, grants and personal fees from Biogen Idec, grants and personal fees from Genzyme Sanofi, grants and personal fees from Bayer Schering Pharma, grants and personal fees from Novartis, and grants and personal fees from Teva, during the conduct of the study. Paolo Gallo reports grants and personal fees from Merck Serono, grants and personal fees from Biogen Idec, grants and personal fees from Genzyme Sanofi, grants and personal fees from Bayer Schering Pharma, grants and personal fees from Novartis, grants and personal fees from Teva, grants from University of Padua, Department of Neurosciences DNS, grants from Veneto Region of Italy, grants from Italian Association for Multiple Sclerosis (AISM), and grants from Italian Ministry of Public Health, during the conduct of the study.
: This study was approved by the local Ethics Committee and was performed according to the Declaration of Helsinki.
: Participants received an explanatory statement and gave their written informed consent to participate in the study.